
Sign up to save your podcasts
Or


On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By POLITICO4.7
453453 ratings
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices

610 Listeners

1,514 Listeners

690 Listeners

112,032 Listeners

963 Listeners

308 Listeners

56,517 Listeners

105 Listeners

493 Listeners

206 Listeners

644 Listeners

6,445 Listeners

142 Listeners

390 Listeners

39 Listeners

11 Listeners

614 Listeners